USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma

Colon adenocarcinoma (COAD) is one of the diseases with the highest morbidity and mortality in the world. At present, immunotherapy has become a valuable method for the treatment of COAD. Tumor mutational burden (TMB) is considered to be the most common biomarker for predicting immunotherapy. Accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuanyuan, Li, Long, Yao, Wenchao, Liu, Xuxu, Yang, Yang, Ma, Biao, Xue, Dongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593250/
https://www.ncbi.nlm.nih.gov/pubmed/34795697
http://dx.doi.org/10.3389/fgene.2021.762160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593250/
https://www.ncbi.nlm.nih.gov/pubmed/34795697
http://dx.doi.org/10.3389/fgene.2021.762160

Ejemplares similares